Abstract
PIM kinases, a small family of serine/threonine kinases, are important intermediates in the cytokine signaling pathway of inflammatory disease. In this study, we investigated whether the novel PIM kinase inhibitor KMU-470, a derivative of indolin-2-one, inhibits lipopolysaccharide (LPS)-induced inflammatory responses in RAW 264.7 cells. We demonstrated that KMU-470 suppressed the production of nitric oxide and inducible nitric oxide synthases that are induced by LPS in RAW 264.7 cells. Furthermore, KMU-470 inhibited LPS-induced up-regulation of TLR4 and MyD88, as well as the phosphorylation of IκB kinase and NF-κB in RAW 264.7 cells. Additionally, KMU-470 suppressed LPS-induced up-regulation at the transcriptional level of various pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-6. Notably, KMU-470 inhibited LPS-induced up-regulation of a major component of the inflammasome complex, NLRP3, in RAW 264.7 cells. Importantly, PIM-1 siRNA transfection attenuated up-regulation of NLRP3 and pro-IL-1β in LPS-treated RAW 264.7 cells. Taken together, these findings indicate that PIM-1 plays a key role in inflammatory signaling and that KMU-470 is a potential anti-inflammatory agent.
References
May 1, 1984·Cell·H T CuypersA Berns
Jan 1, 1996·Critical Reviews in Neurobiology·H Y YunT M Dawson
Jan 1, 1997·Annual Review of Immunology·J MacMickingC Nathan
Feb 15, 2001·American Journal of Physiology. Cell Physiology·E D Chan, D W Riches
Sep 7, 2001·Nature·K A FitzgeraldL A O'Neill
Dec 20, 2003·American Journal of Physiology. Cell Physiology·Mini AgaPaul J Bertics
Dec 15, 2004·Microbes and Infection·Chandrashekhar Pasare, Ruslan Medzhitov
Jul 26, 2005·British Journal of Pharmacology·Yi-Ming ChiangLie-Fen Shyur
Oct 4, 2005·Biochimica Et Biophysica Acta·Bozena Kaminska
Oct 2, 2007·FEMS Immunology and Medical Microbiology·Parul TripathiVinod Singh
Apr 16, 2009·Clinical Microbiology Reviews·Trine H Mogensen
Dec 8, 2010·Critical Reviews in Eukaryotic Gene Expression·Narayanan Parameswaran, Sonika Patial
Apr 27, 2011·Cancer Science·Naofumi MukaidaYing-Yi Li
Oct 25, 2011·Cytokine & Growth Factor Reviews·Gloria Lopez-Castejon, David Brough
Nov 15, 2011·American Journal of Respiratory Cell and Molecular Biology·Yoo Seob ShinErwin W Gelfand
Apr 3, 2012·Digestive Diseases and Sciences·Yue-Ming ShenGui-Ying Zhang
Jun 26, 2012·Bioorganic & Medicinal Chemistry Letters·Les A DakinXiaolan Zheng
Jan 5, 2014·Inflammation·Hao PanXian-Hui He
Mar 4, 2014·International Immunopharmacology·Yun-peng LuoMing-yan Zhao
Apr 17, 2014·PloS One·Maria Ruweka FernandoDerek Mark McKay
Apr 30, 2014·Bioorganic & Medicinal Chemistry Letters·Kunal N MoreJinho Lee
May 13, 2014·American Journal of Physiology. Lung Cellular and Molecular Physiology·M de VriesM C Nawijn
May 16, 2014·International Immunopharmacology·Weihua NiGuixiang Tai
Jun 24, 2014·Chemical & Pharmaceutical Bulletin·Jinho LeeVictor Sukbong Hong
Sep 13, 2014·Journal of Agricultural and Food Chemistry·Se-Eun JangDong-Hyun Kim
Oct 18, 2014·Cold Spring Harbor Perspectives in Biology·Marcel R de ZoeteRichard A Flavell
May 30, 2015·Journal of Agricultural and Food Chemistry·Young-Hee JoJoong-Hyuck Auh
Oct 28, 2015·Journal of Medicinal Chemistry·Matthew T BurgerPablo D Garcia
Nov 13, 2015·Expert Opinion on Therapeutic Patents·Alberto LeoniMirella Rambaldi
May 17, 2018·British Journal of Cancer·Jorge CortesEmma Dean
May 22, 2018·The Journal of Clinical Investigation·Anusara DaenthanasanmakXue-Zhong Yu
Jun 22, 2018·PloS One·Holly KoblishPeggy Scherle
Oct 30, 2018·Journal of Cancer Prevention·Xinning ZhangZhen-Zhen Liu
Jul 28, 2019·Journal of Cellular and Molecular Medicine·Junying Ding, Qingquan Liu